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ABSTRACT Laser Raman spectroscopy has been used to detect structural changes in troponin
C induced by Ca2" binding. Addition of Ca2" to the high affinity Ca2" - Mg2+ sites produces
perturbations in the amide III region of the spectrum indicative of increased a-helical content,
and in regions of the spectrum corresponding to carboxylate, thiol, and phenol side chains.
However, Ca2+ binding to the low affinity Ca2+-specific sites is not detected by laser Raman
spectral changes.
INTRODUCTION
Troponin C (TnC) is the Ca2+-binding subunit of troponin which, together with tropomyosin,
regulates the interaction between actin and myosin in vertebrate skeletal muscle. TnC binds
four calcium ions: there are two sites with a higher affinity (Kapp = 2 x 107M-) that also bind
Mg2+ (Kapp = 5 x 103M '), and two with a lower affinity (Kapp = 5 x 106M-') that are
calcium-specific (1). A model of TnC structure based on its sequence homology with carp
parvalbumin, whose crystal structure is known (2), suggests that each of the four binding sites
consists of a ten-residue loop rich in aspartic and glutamic acid residues, flanked on either side
by a-helical segments. Calcium binding to the two high affinity Ca2+ -Mg2+ sites induces
large increases in secondary (a-helical) and tertiary structure, as indicated by various
spectroscopic techniques (3-9). Calcium binding to the low affinity calcium-speciflc sites,
however, produces more subtle changes detectable with the use of fluorescence probes (5, 10)
and by proton NMR (7, 8).
In this work we have employed laser Raman spectroscopy as another tool to probe
Ca2+-induced changes in TnC. The Raman spectrum of a protein shows a series of peaks
characteristic of the vibrational modes of the various bonds in it. Both the peptide backbone
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and the amino acid side chains contribute to the spectrum, and the identification of the peaks
has been based primarily on comparisons with amino acids, model peptides, and well-
characterized proteins (e.g., see references 11-13). The data presented here show that Ca2"
binding to the Ca2"-Mg2+ sites of TnC produces changes in several regions of the spectrum,
interpretable as increases in secondary structure and as changes in tyrosine, cysteine, and
carboxylate side chains, whereas binding to the lower affinity Ca2+-specific sites does not
produce appreciable spectral changes.
METHODS
Rabbit skeletal TnC was prepared by the method of Potter and Gergely (1). Purified TnC was
lyophilized after dialysis vs. 5 mM EDTA followed by several changes of distilled, deionized water. For
spectroscopic studies, weighed samples of TnC were taken up in a solution containing 0.1 M KCI and 25
mM Hepes buffer at pH 7.4 ± Ca2+. Ten microliter samples were sealed in Kimax glass capillary tubes
(i. d. = 1 mm) at [Tnc] = 1-5 mM. Samples were mounted perpendicularly to the scattering plane and
maintained at I0°C.
The computer-controlled laser Raman spectrophotometer used in this study has been previously
described (14). The instrument was programmed to scan the spectral region from 580 cm-' to 1,780
cm-' at a rate of 5 cm-'/s, signal averaging over 25 scans, giving a spectral resolution < 1 cm-'. Regions
of interest in the spectra were scale-expanded and, when necessary, appropriate corrections were made
to obtain a flat base line.
RESULTS AND DISCUSSION
The amide III region of the Raman spectrum (1,225-1,275 cm-') encompasses peaks
characteristic of protein secondary structure. The spectrum of apo TnC (Fig. 1) contains two
broad major peaks in this region, namely at 1,242 and 1,268 cm- , and two smaller peaks, at
1,253 and 1,260 cm-'. The two higher frequency peaks are characteristic of a-helical
structure, while those at 1,242 and 1,253 cm-' represent disordered structures. Peaks below
1,240 cm-', normally indicating (3-pleats, are absent from the spectrum suggesting only a
minor contribution of (-structure to the protein, in agreement with other studies (2, 15). The
stepwise addition of Ca2` ions to TnC (Fig. 1) results in changes in the spectrum that are
consistent with an increase in a-helical content (16-22) and that are essentially complete at 2
mol metal /mol protein. The changes include a sharpening of the 1,260-cm-' peak and the
appearance of two shoulders at 1,272 and 1,280 cm-'. More difficult to interpret are the
changes at the lower frequencies of the amide III region; namely the increase in the
1,253-cm-' peak and the appearance of an intense peak at 1,236 cm-' with a shoulder at
1,232 cm-'. While peaks in the 1,235-cm-' region are generally interpretable as ,8-pleated
sheets, the circular dichroic (CD) data (15) and models based on the homologous protein
parvalbumin (2) for TnC preclude extensive contributions from such structures. Thus it is
more likely that the triplet of peaks centered at 1,236 cm-' represents nonhydrogen-bonded
disordered structure, as has been reported by Yu et al. (20) for denatured insulin and
proinsulin. One cannot, however, rule out a contribution to this region from the high affinity
calcium-binding loops themselves which probably exist as somewhat extended chains in the
absence of Ca2+ and in considerably tighter reverse (,B) turns in its presence (6, 15). It is
noteworthy that no substantial spectral changes occur in the amide III region as the third and
fourth Ca2+ ions are added to the protein. Addition of Mg2+ to TnC produces qualitatively
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FIGURE 1 Expanded Raman spectrum of amide III region. Conditions: 1mM TnC in solution containing
0.1 M KCI, 25 mM Hepes buffer, pH 7.4, and Ca2" at indicated mole ratios.
similar changes in the spectra of TnC (not shown). The low Mg2' affinity for the protein,
however, makes it difficult to obtain complete saturation of TnC with Mg2+.
The fundamental conclusion to be drawn from the amide III region of the laser Raman
spectrum is that major changes are associated with Ca2' binding to the Ca2,-Mg2+ sites
rather than the Ca2+-specific sites. van Eerd and Kawasaki (3) first showed large increases in
the 222-nm ellipticity of TnC associated with higher affinity site Ca2` binding. Their
observations have been verified by several other studies (3-5, 15) which suggest an increase in
the a-helical content from - 35 to 50% upon the addition of Ca2+ to those sites. Studies on
proteolytic fragments (6) further suggest that most of the increased secondary structure
occurs in the C-terminal half of the molecule, in which the high affinity sites are located.
These results are supported by proton NMR studies on both intact TnC (7-9) and proteolytic
fragments.'
Structural changes associated with Ca2' binding to the low affinity sites have generally
been more difficult to delineate since the secondary and tertiary rearrangements that occur
'Evans, J. S., B. A. Levine, P. C. Leavis, J. Gergely, Z. Grabarek, and W. Drabikowski. Manuscript submitted for
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are apparently small. Several probes (5, 10) have shown changes upon saturating these sites,
and proton NMR studies have indicated subtle tertiary structural changes (7-9, 22). CD
spectra generally indicate very small (5-10%) secondary changes. Two recent studies (23,
24), however, show biphasic calcium titrations with up to 40% of the total CD change
occurring when the two lower affinity sites are titrated. It is somewhat difficult to interpret
these new results because, at values of [Ca2+Iadded > [EGTA]totai (or [Ca2,] - 1 4M), the true
[Ca2+]free values must be different from those reported, owing to the binding of Ca2+ to the
*. ( nm1.
FIGURE 2 Expanded Raman spectrum showing region of CO2- symmetric stretch (1,403-1,411 cm-')
and CH2 side-chain deformation modes (1,418-1427 cm-'). Conditions same as in Fig. 1. Inset: CO2-
symmetric stretch of 10 mM EDTA without Ca2+ (a) and with 10 mM Ca2, (b). EDTA in solution
containing O.1M KC1, 25 mM Hepes buffer, pH 7.4.
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protein. Furthermore, stoichiometric calcium titrations at higher concentrations of TnC do
not bring about large changes in CD and PMR spectra indicative of changes in secondary
structure at [Ca2"]/[TnC] > 2 (3, 7-9, 15, 25). Given these considerations, the absence of
change in the laser Raman spectrum supports the view that calcium binding to the low affinity
sites does not produce large secondary structural changes.
In addition to secondary structural features, several side-chain peaks that change upon
calcium addition can be distinguished in TnC. Raman frequencies between 1,400 and 1,430
cm-' are attributable to carboxylate symmetric stretch (1,405 cm-') and to CH2 vibrations
(1,423 cm-') of glutamic and aspartic acids and lysine residues. Several changes occur at
these frequencies on addition of calcium to the flrst two sites (Fig. 2). First, the predominant
peak in apo TnC (1,405 cm-') is split into peaks at 1,403 and 1,411 cm-'. Comparison of this
result with carboxylate frequencies of EDTA ± Ca2, (Fig. 2 inset) suggests that the
1,403-cm-' peak corresponds to ionized carboxylate groups, while that at 1,411 cm-' is
characteristic of carboxylates coordinated with calcium. The second set of peaks at 1,418 and
1,425 cm -' merges to a single broad peak at 1,423 cm-'.
It is somewhat puzzling that the carboxylate peaks do not show significant changes at
[Ca2J]/[TnC] > 2, since carboxylates are involved as Ca2+-binding ligands in the sites of
lower affinity, as well as in those of higher affinity. The lack of change beyond 2 Ca2, may
reflect the fact that carboxylate-containing residues in the lower affinity sites are in a highly
structured environment even in the absence of bound metal, in contrast to those in the high
affinity sites (7-9), thus imposing restrictions on symmetric stretch modes.
Tyrosine ring modes give rise to Raman peaks at - 853, 828, and 646 cm-' (Figs. 3 and 4).
The relative intensities of the first two have been shown (26) to be related primarily to the
state of the phenolic OH; namely I850/I830 < 0.9 in cases where a phenolic hydroxyl is
a
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FIGURE 3 Expanded Raman spectrum of tyrosine ring modes. Conditions same as in Fig. 1. Apo.TnC
(a), Ca" -TnC (b).
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FIGURE 4 Expanded Raman spectrum showing phenylalanine ring twist (620 cm-'), tyrosine ring twist
(646-652 cm-'), and C-S stretch (662 cm-'). Conditions same as in Fig. 1.
H-bonded to a negatively charged acceptor, whereas H-bonding between an acidic donor and
a phenolic oxygen generally yields I850/I830 > 0.9. The ratio of 0.5 for the integrated intensities
of these two peaks in apo-TnC (Fig. 3 a) indicates that the former case prevails, which is
consistent with the fact that one of the two tyrosines, Tyr-109, is located within a
Ca2"-binding site rich in aspartic and glutamic acid residues available for H-bonding (27).
Binding two Ca2" ions per molecule of TnC results in a shift of the I850/I830 ratio to 1.0 (Fig.
3 b), suggesting that the acceptor of the phenolic proton is not available for hydrogen bonding
in the Ca2+-bound state. The 850/830 cm-' doublet intensity ratio is also influenced by the
degree of exposure of tyrosine residues to the solvent (26). In the case of TnC, however, this
can be ruled out as contributing to the observed ratios, since tyrosine fluorescence quenching
studies (unpublished; P. C. Leavis and S. S. Lehrer) indicate that the solvent exposure of both
tyrosine residues (Tyr-10 and Tyr- 109) is unaffected by Ca2" binding.
The single symmetrical peak at 645 cm- ' corresponding to a tyrosine ring mode (Fig. 4) in
the apo-TnC spectrum splits into two peaks at 646 and 652 cm- 'upon addition of the first two
Ca2" ions. This split is consistent with the view that of the two tyrosine residues in TnC, only
Tyr-109 experiences a change in environment upon Ca2' binding (6, 28).
The only other Ca2"-induced change in the Raman spectrum occurs in the region of C-S
stretch. The peak at 662 cm-' is assignable to the single Cys residue in TnC (Cys-98). It
intensifies severalfold upon the addition of the first two Ca2, ions and then appears to broaden
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slightly as the last two Ca2" are added. Again the present results indicating a Ca2"-induced
change in the environment of Cys-98 are consistent with previous studies in which this
cysteine residue either has been labeled with extrinsic probes or its reactivity as a function of
Ca2" concentration has been studied (5). The slight further change in the C-S stretch upon
addition of the third and fourth Ca2" ions indicates that low-affinity-site Ca2" binding
produces changes in the polypeptide chain in the vicinity of Cys-98. This is also suggested by a
fluorescent probe on Cys-98 (5).
CONCLUSION
It is apparent that interpretation of Raman spectral changes in TnC is generally consistent
with information derived using other techniques. The access to information about specific
groups of residues in proteins afforded by Raman spectroscopy bodes well for its successful
use in further studies on TnC and the other troponin subunits now under way in this
laboratory.
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